MODERNA MESSENGER THERAPEUTICS Trademark

Trademark Overview

On Tuesday, January 4, 2022, a trademark application was filed for MODERNA MESSENGER THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the MODERNA MESSENGER THERAPEUTICS trademark a serial number of 97202151. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, January 1, 2024. This trademark is owned by ModernaTx, Inc.. The MODERNA MESSENGER THERAPEUTICS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

scientific research in the fields of pharmaceuticals, vaccines, medicine, biologics, biotherapeutics, biosimilars and therapeutics
moderna messenger therapeutics

General Information

Serial Number97202151
Word MarkMODERNA MESSENGER THERAPEUTICS
Filing DateTuesday, January 4, 2022
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, January 1, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 4, 2023

Trademark Statements

Translation of Words in MarkThe English translation of the word "MODERNA" in the mark is "MODERN".
Disclaimer with Predetermined Text"MESSENGER THERAPEUTICS"
Goods and Servicesscientific research in the fields of pharmaceuticals, vaccines, medicine, biologics, biotherapeutics, biosimilars and therapeutics

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, January 7, 2022
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameModernaTx, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139
Party NameModernaTx, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139

Trademark Events

Event DateEvent Description
Tuesday, January 2, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, January 1, 2024ABANDONMENT - NO USE STATEMENT FILED
Wednesday, August 30, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, August 30, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, August 30, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, August 30, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, August 30, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, August 10, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, August 10, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, August 10, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, August 10, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, August 10, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, May 30, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 4, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 4, 2023PUBLISHED FOR OPPOSITION
Wednesday, March 15, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, March 1, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, February 28, 2023EXAMINER'S AMENDMENT ENTERED
Tuesday, February 28, 2023ASSIGNED TO LIE
Tuesday, February 28, 2023NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, February 28, 2023EXAMINERS AMENDMENT E-MAILED
Tuesday, February 28, 2023EXAMINERS AMENDMENT -WRITTEN
Tuesday, November 15, 2022PREVIOUS ALLOWANCE COUNT WITHDRAWN
Tuesday, November 8, 2022WITHDRAWN FROM PUB - OG REVIEW QUERY
Wednesday, October 26, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, October 8, 2022ASSIGNED TO EXAMINER
Friday, January 7, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, January 7, 2022NEW APPLICATION ENTERED

Related Keywords

therapeutics messenger moderna biologics biotherapeutics biosimilars medicine vaccines research fields pharmaceuticals scientific